See more : NWS Holdings Limited (0659.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Sihuan Pharmaceutical Holdings Group Ltd. (0460.HK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Sihuan Pharmaceutical Holdings Group Ltd., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- KNOT Offshore Partners LP (KNOP) Income Statement Analysis – Financial Results
- Eco Innovation Group, Inc. (ECOX) Income Statement Analysis – Financial Results
- PETRONAS Dagangan Berhad (PNADF) Income Statement Analysis – Financial Results
- Ipca Laboratories Limited (IPCALAB.BO) Income Statement Analysis – Financial Results
- Liquid Media Group Ltd. (YVRLF) Income Statement Analysis – Financial Results
Sihuan Pharmaceutical Holdings Group Ltd. (0460.HK)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.sihuanpharm.com
About Sihuan Pharmaceutical Holdings Group Ltd.
Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in the People's Republic of China. It offers drugs in the oncology, metabolic diseases, digestive system, and other therapeutic areas. The company is also involved in the investment and sale of medical beauty products; manufacture of medical instruments; investment in properties; construction for medical projects; and project preparation for pharmaceutical products manufacturing. In addition, it provides information support, general hospital, hospital management, biotechnology promotion, and medical aesthetic research and development services. The company was founded in 2001 and is based in Wanchai, Hong Kong.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.86B | 2.18B | 3.04B | 2.46B | 2.88B | 2.92B | 2.75B | 3.19B | 3.17B | 3.08B | 4.73B | 3.04B | 2.24B | 1.04B | 708.91M | 510.05M | 286.35M | 161.78M |
| Cost of Revenue | 564.90M | 693.61M | 607.90M | 549.78M | 588.99M | 538.32M | 758.96M | 996.75M | 939.16M | 972.81M | 1.03B | 753.12M | 527.60M | 292.14M | 191.92M | 133.55M | 60.53M | 36.90M |
| Gross Profit | 1.30B | 1.49B | 2.43B | 1.91B | 2.29B | 2.38B | 1.99B | 2.19B | 2.23B | 2.11B | 3.70B | 2.29B | 1.71B | 744.74M | 516.99M | 376.50M | 225.82M | 124.87M |
| Gross Profit Ratio | 69.64% | 68.20% | 79.99% | 77.69% | 79.54% | 81.55% | 72.36% | 68.71% | 70.35% | 68.46% | 78.17% | 75.25% | 76.47% | 71.83% | 72.93% | 73.82% | 78.86% | 77.19% |
| Research & Development | 592.01M | 1.08B | 1.03B | 878.69M | 598.95M | 480.33M | 303.93M | 169.37M | 143.88M | 148.65M | 83.63M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 468.96M | 552.19M | 592.22M | 489.78M | 471.57M | 396.11M | 325.10M | 540.47M | 455.85M | 480.14M | 326.83M | 206.64M | 201.09M | 128.83M | 78.81M | 53.41M | 38.86M | 11.63M |
| Selling & Marketing | 442.26M | 471.14M | 536.74M | 368.79M | 245.38M | 271.12M | 227.63M | 145.77M | 155.11M | 150.16M | 2.33B | 1.31B | 631.57M | 56.65M | 48.81M | 38.91M | 23.66M | 16.27M |
| SG&A | 911.22M | 1.02B | 1.13B | 858.58M | 716.95M | 667.23M | 552.74M | 686.23M | 610.96M | 630.31M | 2.66B | 1.52B | 832.66M | 185.48M | 127.62M | 92.31M | 62.52M | 27.90M |
| Other Expenses | -369.28M | 15.77M | 24.99M | 27.65M | 30.32M | 31.69M | 12.76M | 36.50M | -11.23M | 38.57M | 1.81M | -11.70M | -108.54M | 0.00 | 2.36M | 4.28M | -10.69M | -12.03M |
| Operating Expenses | 1.13B | 3.55B | 1.98B | 1.28B | 4.88B | 525.42M | 355.21M | 147.70M | 503.93M | 149.17M | 2.25B | 1.26B | 724.12M | 185.48M | 127.62M | 80.24M | 51.83M | 15.87M |
| Cost & Expenses | 1.70B | 4.24B | 2.59B | 1.83B | 5.47B | 1.06B | 1.11B | 1.14B | 1.44B | 1.12B | 3.28B | 2.01B | 1.25B | 477.62M | 319.53M | 213.79M | 112.36M | 52.77M |
| Interest Income | 147.91M | 64.38M | 46.60M | 127.51M | 164.99M | 158.50M | 97.43M | 111.32M | 109.76M | 111.17M | 97.71M | 126.84M | 56.37M | 23.63M | 6.24M | 4.26M | 1.27M | 0.00 |
| Interest Expense | 269.34M | 211.18M | 117.35M | 8.22M | 4.87M | 6.06M | 46.00K | 210.00K | 160.00K | 5.82M | 8.06M | 6.98M | 1.86M | 1.86M | 592.00K | 3.39M | 176.00K | 464.00K |
| Depreciation & Amortization | 226.23M | 369.81M | 309.37M | 278.28M | 354.70M | 307.24M | 297.05M | 291.02M | 219.17M | 172.69M | 195.86M | 132.23M | 95.31M | 36.04M | 28.55M | 26.39M | 14.39M | 10.23M |
| EBITDA | 334.31M | -1.54B | 931.69M | 714.06M | -2.06B | 1.92B | 1.68B | 2.18B | 2.29B | 2.15B | 1.81B | 1.30B | 1.14B | 618.93M | 410.17M | 322.65M | 185.60M | 119.09M |
| EBITDA Ratio | 17.97% | -10.51% | 30.66% | 28.98% | 56.60% | 65.72% | 61.16% | 68.47% | 72.43% | 69.77% | 37.23% | 41.95% | 50.94% | 59.69% | 60.17% | 68.04% | 69.59% | 73.71% |
| Operating Income | 161.70M | -536.03M | 676.20M | 485.82M | 1.39B | 1.72B | 1.47B | 1.94B | 2.07B | 1.98B | 1.46B | 1.05B | 990.35M | 613.31M | 373.03M | 300.52M | 184.63M | 108.85M |
| Operating Income Ratio | 8.69% | -24.58% | 22.26% | 19.71% | 48.45% | 59.08% | 53.35% | 60.75% | 65.51% | 64.17% | 30.89% | 34.44% | 44.17% | 59.15% | 52.62% | 58.92% | 64.48% | 67.29% |
| Total Other Income/Expenses | -322.96M | -292.05M | -275.93M | 280.03M | -16.73M | 288.56M | 264.07M | 217.18M | 767.06M | 94.33M | 70.31M | 117.79M | 54.51M | 21.77M | 8.00M | -13.45M | 11.98M | -464.00K |
| Income Before Tax | -161.26M | -2.12B | 496.01M | 765.84M | -2.42B | 2.01B | 1.73B | 2.15B | 2.84B | 2.07B | 1.57B | 1.17B | 1.04B | 635.08M | 381.03M | 287.07M | 184.45M | 108.39M |
| Income Before Tax Ratio | -8.67% | -97.32% | 16.32% | 31.08% | -84.18% | 68.97% | 62.97% | 67.57% | 89.72% | 67.23% | 33.12% | 38.31% | 46.60% | 61.25% | 53.75% | 56.28% | 64.42% | 67.00% |
| Income Tax Expense | 96.43M | 196.79M | 253.12M | 219.04M | 290.39M | 332.80M | 250.17M | 472.73M | 796.95M | 388.54M | 257.37M | 244.00M | 244.82M | 128.18M | 67.37M | 53.62M | 5.63M | 18.22M |
| Net Income | -54.02M | -1.95B | 416.51M | 473.38M | -2.71B | 1.62B | 1.45B | 1.71B | 2.06B | 1.67B | 1.30B | 904.40M | 824.05M | 522.07M | 326.32M | 237.06M | 179.27M | 90.45M |
| Net Income Ratio | -2.90% | -89.46% | 13.71% | 19.21% | -94.13% | 55.53% | 52.77% | 53.62% | 65.12% | 54.19% | 27.53% | 29.73% | 36.75% | 50.35% | 46.03% | 46.48% | 62.60% | 55.91% |
| EPS | -0.01 | -0.21 | 0.05 | 0.05 | -0.29 | 0.17 | 0.15 | 0.17 | 0.20 | 0.16 | 0.12 | 0.09 | 0.08 | 0.07 | 0.03 | 0.02 | 0.02 | 0.01 |
| EPS Diluted | -0.01 | -0.21 | 0.05 | 0.05 | -0.29 | 0.17 | 0.15 | 0.17 | 0.20 | 0.16 | 0.12 | 0.09 | 0.08 | 0.07 | 0.03 | 0.02 | 0.02 | 0.01 |
| Weighted Avg Shares Out | 9.30B | 9.33B | 9.43B | 9.47B | 9.47B | 9.47B | 9.48B | 10.14B | 10.36B | 10.36B | 10.35B | 10.35B | 10.36B | 8.01B | 10.00B | 10.00B | 10.00B | 10.00B |
| Weighted Avg Shares Out (Dil) | 9.30B | 9.33B | 9.48B | 9.47B | 9.47B | 9.47B | 9.48B | 10.14B | 10.36B | 10.36B | 10.35B | 10.35B | 10.36B | 8.01B | 10.00B | 10.00B | 10.00B | 10.00B |
Source: https://incomestatements.info
Category: Stock Reports